Skip to Content

New Drug Approvals Archive - August 2003

August 2003

Crestor (rosuvastatin calcium) Tablets

Date of Approval: August 12, 2003
Company: AstraZeneca
Treatment for: Heterozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia, Prevention of Cardiovascular Disease

Crestor is an HMG-CoA reductase inhibitor approved as an adjunct to diet for the treatment of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia. Crestor is also indicated for the primary prevention of cardiovascular disease.

Levitra (vardenafil hydrochloride) Tablets

Date of Approval: August 19, 2003
Company: Bayer Corporation
Treatment for: Erectile Dysfunction

Levitra is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.

Gamunex (immune globulin intravenous (human)) Injection

Date of Approval: August 27, 2003
Company: Bayer Corporation
Treatment for: Primary Immunodeficiency Syndrome, Idiopathic (Immune) Thrombocytopenic Purpura, Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Gamunex (immune globulin intravenous (human)) is indicated for the treatment of primary humoral immunodeficiency, idiopathic thrombocytopenic purpura and chronic inflammatory demyelinating polyneuropathy (CIDP).

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.